| Open Document File Size: 91,06 KBShare Result on Facebook
Company HP / / Continent North America / Europe / / Country Mexico / United States / Brazil / / Facility The University of Texas MD Anderson Cancer Center / / IndustryTerm tongue tumor site / prevention of HPV-related disease / prevention of HPV-related oropharyngeal cancer / healthcare providers / / MedicalCondition HPVassociated cancers / cervical cancers / oropharyngeal cancer / HPV-positive cancers / epidemic / both prevalent and incident oral HPV infection / oral infections / genital infections / oropharyngeal cancers / genital warts / HPV-positive oropharyngeal cancer / head and neck cancer / tongue cancer / head tumors / prevalent infections / infections / head cancers / sexually transmitted infection / neck tumors / cancers / tumor / oral infection / oral HPV infection / large tumors / tongue tumor / cancer / tumors / disease / prevalent infection / HPV-related disease / HPV / cervical cancer / HPV infections / genital infection / prevalent oral infections / HPV-related oropharyngeal cancer / HPV-positive oropharyngeal cancers / persistent infection / cervical infections / neck cancers / HPV-negative cancers / infection / HPV-positive tumors / oral cavity cancer / / MedicalTreatment immunization / vaccination / immunosuppression / Head and Neck Surgery / / Organization World Health Organization / International Agency for the Research / FDA / HPV association / University of Texas / / Person Kristina Dahlstrom / / Position representative of the U.S. population / instructor in the Department / HPVrelated head / pediatrician / HPV-unrelated head / / ProvinceOrState Texas / / Technology antibodies / apoptosis / /
SocialTag |
Hi. I’m Kristina Dahlstrom, an instructor in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center. My lecture today will be on the epidemiology of oropharyngeal cancer. The objec